Selected article for: "clinical response and medical treatment"
Author: Bernal-Torres, Wikler; Herrera-Escandón, Álvaro; Hurtado-Rivera, Manuel; Plata-Mosquera, Carlos Andrés
Title: COVID-19 fulminant myocarditis: a case report
  • Cord-id: ip6llx7r
  • Document date: 2020_7_8
    • ID: ip6llx7r
    Snippet: BACKGROUND: Fulminant myocarditis is a catastrophic disease with high mortality and complications. A viral aetiology is frequent and the implication of SARS-CoV-2 is not yet known. CASE SUMMARY: A 38-year-old woman who recently arrived from Spain presented with palpitations that started suddenly 3 days prior to presentation and were associated with haemodynamic instability, without dyspnoea or chest pain. We found features of myopericarditis on the electrocardiogram and severe systolic dysfuncti
    Document: BACKGROUND: Fulminant myocarditis is a catastrophic disease with high mortality and complications. A viral aetiology is frequent and the implication of SARS-CoV-2 is not yet known. CASE SUMMARY: A 38-year-old woman who recently arrived from Spain presented with palpitations that started suddenly 3 days prior to presentation and were associated with haemodynamic instability, without dyspnoea or chest pain. We found features of myopericarditis on the electrocardiogram and severe systolic dysfunction on the echocardiogram. The chest tomography showed findings which suggested COVID-19 infection, and PCR for SARS-CoV-2 was positive. The cardiac magnetic resonance image showed Lake Louise criteria for myocarditis. The patient was treated with immunomodulatory, steroid, and immunoglobulin therapy, with a favourable clinical response. DISCUSSION: The importance of this case lies in highlighting the severe cardiac involvement in a young patient, without previous risk factors, positive for COVID-19, and the favourable response to the medical treatment given.

    Search related documents:
    Co phrase search for related documents
    • acid amplification and low respiratory: 1, 2, 3, 4
    • acid amplification and magnetic resonance: 1
    • acute myopericarditis and lopinavir ritonavir: 1
    • acute myopericarditis and magnetic resonance: 1, 2, 3, 4
    • lopinavir ritonavir and low respiratory: 1, 2
    • lopinavir ritonavir and low respiratory tract: 1
    • lopinavir ritonavir and lung involvement: 1, 2, 3, 4, 5
    • lopinavir ritonavir and lung parenchyma: 1
    • lopinavir ritonavir and magnetic resonance: 1, 2, 3, 4, 5
    • low respiratory and lung involvement: 1, 2
    • low respiratory and lung parenchyma: 1, 2
    • low respiratory and magnetic resonance: 1
    • lung involvement and magnetic resonance: 1, 2, 3
    • lung parenchyma and magnetic resonance: 1, 2